{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:20:48Z","timestamp":1787793648940,"version":"build-2784847793"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75678-2","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T13:45:38Z","timestamp":1784209538000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triple IFN pathway deficiency sensitizes mice to human respiratory virus infection independent of human viral receptor expression"],"prefix":"10.1038","volume":"17","author":[{"given":"Qinghong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiquan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3019-3272","authenticated-orcid":false,"given":"Jingrong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-2074","authenticated-orcid":false,"given":"Liqiang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-1411","authenticated-orcid":false,"given":"Haisheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6011-3101","authenticated-orcid":false,"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5067-659X","authenticated-orcid":false,"given":"Xiaoping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3169-6349","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"75678_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit, E., van Doremalen, N., Falzarano, D. & Munster, V. J. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol 14, 523\u2013534 (2016).","journal-title":"Nat. Rev. Microbiol"},{"key":"75678_CR2","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S1473-3099(14)70840-0","volume":"14","author":"JA Al-Tawfiq","year":"2014","unstructured":"Al-Tawfiq, J. A. et al. Surveillance for emerging respiratory viruses. Lancet Infect. Dis. 14, 992\u20131000 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"75678_CR3","unstructured":"World Health Organization. WHO Launches Global Framework for Understanding the Origins of New or Re-emerging Pathogens. https:\/\/www.who.int\/news\/item\/04-09-2024-who-launches-global-framework-for-understanding-the-origins-of-new-or-re-emerging-pathogens (2024)."},{"key":"75678_CR4","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1016\/S2214-109X(19)30264-5","volume":"7","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob. Health 7, e1031\u2013e1045 (2019).","journal-title":"Lancet Glob. Health"},{"key":"75678_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/resp.14818","volume":"29","author":"TJ An","year":"2024","unstructured":"An, T. J., Lee, J., Shin, M. & Rhee, C. K. Seasonality of common respiratory viruses: analysis of nationwide time-series data. Respirology 29, 985\u2013993 (2024).","journal-title":"Respirology"},{"key":"75678_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41579-023-00919-w","volume":"21","author":"AC Langedijk","year":"2023","unstructured":"Langedijk, A. C. & Bont, L. J. Respiratory syncytial virus infection and novel interventions. Nat. Rev. Microbiol. 21, 734\u2013749 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"75678_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42826-022-00128-1","volume":"38","author":"P Mukherjee","year":"2022","unstructured":"Mukherjee, P., Roy, S., Ghosh, D. & Nandi, S. K. Role of animal models in biomedical research: a review. Lab Anim. Res. 38, 18 (2022).","journal-title":"Lab Anim. Res."},{"key":"75678_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","volume":"586","author":"KH Dinnon","year":"2020","unstructured":"Dinnon, K. H. et al. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature 586, 560\u2013566 (2020).","journal-title":"Nature"},{"key":"75678_CR9","doi-asserted-by":"publisher","first-page":"12982","DOI":"10.1128\/JVI.01571-14","volume":"88","author":"VA Meliopoulos","year":"2014","unstructured":"Meliopoulos, V. A. et al. Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism. J. Virol. 88, 12982\u201312991 (2014).","journal-title":"J. Virol."},{"key":"75678_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nature12391","volume":"501","author":"JA Belser","year":"2013","unstructured":"Belser, J. A. et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature 501, 556\u2013559 (2013).","journal-title":"Nature"},{"key":"75678_CR11","doi-asserted-by":"publisher","first-page":"8172","DOI":"10.1128\/JVI.00621-10","volume":"84","author":"JL Americo","year":"2010","unstructured":"Americo, J. L., Moss, B. & Earl, P. L. Identification of wild-derived inbred mouse strains highly susceptible to monkeypox virus infection for use as small animal models. J. Virol. 84, 8172\u20138180 (2010).","journal-title":"J. Virol."},{"key":"75678_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2220415120","volume":"120","author":"JL Americo","year":"2023","unstructured":"Americo, J. L., Earl, P. L. & Moss, B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc. Natl. Acad. Sci. USA 120, e2220415120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75678_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16798-1","volume":"11","author":"AN Roth","year":"2020","unstructured":"Roth, A. N. et al. Norovirus infection causes acute self-resolving diarrhea in wild-type neonatal mice. Nat. Commun. 11, 2968 (2020).","journal-title":"Nat. Commun."},{"key":"75678_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41586-022-04895-8","volume":"607","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S. et al. Enteric viruses replicate in salivary glands and infect through saliva. Nature 607, 345\u2013350 (2022).","journal-title":"Nature"},{"key":"75678_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280 (2020).","journal-title":"Cell"},{"key":"75678_CR16","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","volume":"583","author":"L Bao","year":"2020","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature 583, 830\u2013833 (2020).","journal-title":"Nature"},{"key":"75678_CR17","doi-asserted-by":"publisher","first-page":"e00747","DOI":"10.1128\/JVI.00747-20","volume":"94","author":"Y Feng","year":"2020","unstructured":"Feng, Y. et al. Human desmoglein-2 and human CD46 mediate human adenovirus Type 55 infection, but human desmoglein-2 plays the major roles. J. Virol. 94, e00747\u201300720 (2020).","journal-title":"J. Virol."},{"key":"75678_CR18","doi-asserted-by":"publisher","first-page":"e01048","DOI":"10.1128\/mSphere.01048-20","volume":"6","author":"Y Jin","year":"2021","unstructured":"Jin, Y. et al. Pathogenesis study of enterovirus 71 using a novel human SCARB2 knock-in mouse model. mSphere 6, e01048\u201301020 (2021).","journal-title":"mSphere"},{"key":"75678_CR19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/cmi.2013.66","volume":"11","author":"H Li","year":"2014","unstructured":"Li, H. et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol. Immunol. 11, 175\u2013183 (2014).","journal-title":"Cell Mol. Immunol."},{"key":"75678_CR20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt1326","volume":"25","author":"H Azuma","year":"2007","unstructured":"Azuma, H. et al. Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice. Nat. Biotechnol. 25, 903\u2013910 (2007).","journal-title":"Nat. Biotechnol."},{"key":"75678_CR21","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","volume":"591","author":"A Wahl","year":"2021","unstructured":"Wahl, A. et al. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801. Nature 591, 451\u2013457 (2021).","journal-title":"Nature"},{"key":"75678_CR22","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.7150\/thno.58321","volume":"11","author":"W Fu","year":"2021","unstructured":"Fu, W. et al. A SCID mouse-human lung xenograft model of SARS-CoV-2 infection. Theranostics 11, 6607\u20136615 (2021).","journal-title":"Theranostics"},{"key":"75678_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110714","volume":"39","author":"DJ Kenney","year":"2022","unstructured":"Kenney, D. J. et al. Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection. Cell Rep. 39, 110714 (2022).","journal-title":"Cell Rep."},{"key":"75678_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19684-y","volume":"11","author":"R Boudewijns","year":"2020","unstructured":"Boudewijns, R. et al. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat. Commun. 11, 5838 (2020).","journal-title":"Nat. Commun."},{"key":"75678_CR25","doi-asserted-by":"publisher","first-page":"e1005084","DOI":"10.1371\/journal.ppat.1005084","volume":"11","author":"K Toth","year":"2015","unstructured":"Toth, K. et al. STAT2 knockout Syrian Hamsters support enhanced replication and pathogenicity of human adenovirus, revealing an important role of type I interferon response in viral control. PLoS Pathog. 11, e1005084 (2015).","journal-title":"PLoS Pathog."},{"key":"75678_CR26","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu, H. et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science 369, 1603\u20131607 (2020).","journal-title":"Science"},{"key":"75678_CR27","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085.e1012 (2020).","journal-title":"Cell"},{"key":"75678_CR28","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1371\/journal.ppat.0030005","volume":"3","author":"A Roberts","year":"2007","unstructured":"Roberts, A. et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB\/c mice. PLoS Pathog. 3, e5 (2007).","journal-title":"PLoS Pathog."},{"key":"75678_CR29","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1128\/JVI.00062-06","volume":"80","author":"S Shresta","year":"2006","unstructured":"Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R. & Harris, E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80, 10208\u201310217 (2006).","journal-title":"J. Virol."},{"key":"75678_CR30","doi-asserted-by":"publisher","first-page":"S248","DOI":"10.1086\/514292","volume":"179","author":"M Bray","year":"1999","unstructured":"Bray, M., Davis, K., Geisbert, T., Schmaljohn, C. & Huggins, J. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 179, S248\u2013S258 (1999).","journal-title":"J. Infect. Dis."},{"key":"75678_CR31","doi-asserted-by":"publisher","first-page":"4480","DOI":"10.1016\/j.cell.2025.06.044","volume":"188","author":"D Boehmer","year":"2025","unstructured":"Boehmer, D. & Zanoni, I. Interferons in health and disease. Cell 188, 4480\u20134504 (2025).","journal-title":"Cell"},{"key":"75678_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"75678_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112907","volume":"42","author":"L Dalskov","year":"2023","unstructured":"Dalskov, L., Gad, H. H. & Hartmann, R. Viral recognition and the antiviral interferon response. EMBO J. 42, e112907 (2023).","journal-title":"EMBO J."},{"key":"75678_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2016","volume":"384","author":"J-L Casanova","year":"2024","unstructured":"Casanova, J.-L., MacMicking, J. D. & Nathan, C. F. Interferon-\u03b3 and infectious diseases: lessons and prospects. Science 384, eadl2016 (2024).","journal-title":"Science"},{"key":"75678_CR35","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"75678_CR36","doi-asserted-by":"publisher","first-page":"13350","DOI":"10.1128\/JVI.79.21.13350-13361.2005","volume":"79","author":"MA Samuel","year":"2005","unstructured":"Samuel, M. A. & Diamond, M. S. Alpha\/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79, 13350\u201313361 (2005).","journal-title":"J. Virol."},{"key":"75678_CR37","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1128\/JVI.73.6.5196-5200.1999","volume":"73","author":"E Cantin","year":"1999","unstructured":"Cantin, E., Tanamachi, B., Openshaw, H., Mann, J. & Clarke, K. Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J. Virol. 73, 5196\u20135200 (1999).","journal-title":"J. Virol."},{"key":"75678_CR38","doi-asserted-by":"publisher","first-page":"e02079","DOI":"10.1128\/JVI.02079-16","volume":"91","author":"MT Baldridge","year":"2017","unstructured":"Baldridge, M. T. et al. Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against Norovirus and Reovirus. J. Virol. 91, e02079\u201302016 (2017).","journal-title":"J. Virol."},{"key":"75678_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.63.2.4","volume":"63","author":"H Yun","year":"2022","unstructured":"Yun, H., Yin, X.-T., Stuart, P. M. & St Leger, A. J. Sensory nerve retraction and sympathetic nerve innervation contribute to immunopathology of murine recurrent herpes stromal keratitis. Invest Ophthalmol. Vis. Sci. 63, 4 (2022).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"75678_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02194-22","volume":"13","author":"CD Patil","year":"2022","unstructured":"Patil, C. D., Suryawanshi, R. K., Kapoor, D. & Shukla, D. Postinfection metabolic reprogramming of the murine trigeminal ganglion limits herpes simplex virus-1 replication. mBio 13, e0219422 (2022).","journal-title":"mBio"},{"key":"75678_CR41","doi-asserted-by":"publisher","first-page":"7051","DOI":"10.1016\/j.vaccine.2015.09.112","volume":"33","author":"VV Sarathy","year":"2015","unstructured":"Sarathy, V. V., Milligan, G. N., Bourne, N. & Barrett, A. D. T. Mouse models of dengue virus infection for vaccine testing. Vaccine 33, 7051\u20137060 (2015).","journal-title":"Vaccine"},{"key":"75678_CR42","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/eji.202048793","volume":"51","author":"I Meyts","year":"2021","unstructured":"Meyts, I. & Casanova, J.-L. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur. J. Immunol. 51, 1039\u20131061 (2021).","journal-title":"Eur. J. Immunol."},{"key":"75678_CR43","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1126\/science.8456301","volume":"259","author":"S Huang","year":"1993","unstructured":"Huang, S. et al. Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742\u20131745 (1993).","journal-title":"Science"},{"key":"75678_CR44","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.4049\/jimmunol.180.4.2474","volume":"180","author":"N Ank","year":"2008","unstructured":"Ank, N. et al. An important role for type III interferon (IFN-lambda\/IL-28) in TLR-induced antiviral activity. J. Immunol. 180, 2474\u20132485 (2008).","journal-title":"J. Immunol."},{"key":"75678_CR45","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3201\/eid2607.191707","volume":"26","author":"J Hang","year":"2020","unstructured":"Hang, J. et al. Human adenovirus type 55 distribution, regional persistence, and genetic variability. Emerg. Infect. Dis. 26, 1497\u20131505 (2020).","journal-title":"Emerg. Infect. Dis."},{"key":"75678_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2307513","volume":"13","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews. Emerg. Microbes Infect. 13, 2307513 (2024).","journal-title":"Emerg. Microbes Infect."},{"key":"75678_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7777","volume":"7","author":"SA Dick","year":"2022","unstructured":"Dick, S. A. et al. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci. Immunol. 7, eabf7777 (2022).","journal-title":"Sci. Immunol."},{"key":"75678_CR48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211846","volume":"219","author":"D Domanska","year":"2022","unstructured":"Domanska, D. et al. Single-cell transcriptomic analysis of human colonic macrophages reveals niche-specific subsets. J. Exp. Med. 219, e20211846 (2022).","journal-title":"J. Exp. Med."},{"key":"75678_CR49","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.immuni.2022.08.010","volume":"55","author":"H Aegerter","year":"2022","unstructured":"Aegerter, H., Lambrecht, B. N. & Jakubzick, C. V. Biology of lung macrophages in health and disease. Immunity 55, 1564\u20131580 (2022).","journal-title":"Immunity"},{"key":"75678_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.111975","volume":"28","author":"Y Nakayama","year":"2025","unstructured":"Nakayama, Y. et al. Targeted labeling and depletion of alveolar macrophages using VeDTR mouse technology. iScience 28, 111975 (2025).","journal-title":"iScience"},{"key":"75678_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1378\/chest.13-1186","volume":"145","author":"B Cao","year":"2014","unstructured":"Cao, B. et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest 145, 79\u201386 (2014).","journal-title":"Chest"},{"key":"75678_CR52","doi-asserted-by":"crossref","unstructured":"Eurosurveillance Editorial Team. Note from the editors: WHO declares mpox outbreak a public health emergency of international concern. Euro Surveill. 29, 240815v (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.33.240815v"},{"key":"75678_CR53","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill, J. P. et al. Monkeypox virus infection in humans across 16 countries\u2014April\u2013June 2022. N. Engl. J. Med. 387, 679\u2013691 (2022).","journal-title":"N. Engl. J. Med."},{"key":"75678_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.hlife.2025.03.003","volume":"3","author":"Q Fan","year":"2025","unstructured":"Fan, Q. et al. Modeling the pathogenic infection of mpox virus clade IIb in type I and II interferon pathway double deficient mice. hLife 3, 297\u2013300 (2025).","journal-title":"hLife"},{"key":"75678_CR55","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-0036-1584798","volume":"37","author":"AR Branche","year":"2016","unstructured":"Branche, A. R. & Falsey, A. R. Parainfluenza virus infection. Semin Respir. Crit. Care Med. 37, 538\u2013554 (2016).","journal-title":"Semin Respir. Crit. Care Med."},{"key":"75678_CR56","doi-asserted-by":"publisher","first-page":"e1077","DOI":"10.1016\/S2214-109X(21)00218-7","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis. Lancet Glob. Health 9, e1077\u2013e1087 (2021).","journal-title":"Lancet Glob. Health"},{"key":"75678_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52071-5","volume":"15","author":"Y Lin","year":"2024","unstructured":"Lin, Y. et al. A robust mouse model of HPIV-3 infection and efficacy of GS-441524 against virus-induced lung pathology. Nat. Commun. 15, 7765 (2024).","journal-title":"Nat. Commun."},{"key":"75678_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26760-4","volume":"12","author":"RM Cox","year":"2021","unstructured":"Cox, R. M. et al. Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets. Nat. Commun. 12, 6415 (2021).","journal-title":"Nat. Commun."},{"key":"75678_CR59","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"75678_CR60","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"75678_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","volume":"28","author":"S-H Sun","year":"2020","unstructured":"Sun, S.-H. et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe 28, 124\u2013133.e124 (2020).","journal-title":"Cell Host Microbe"},{"key":"75678_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s44298-024-00043-3","volume":"2","author":"R Koolaparambil Mukesh","year":"2024","unstructured":"Koolaparambil Mukesh, R., Yinda, C. K., Munster, V. J. & van Doremalen, N. Beyond COVID-19: the promise of next-generation coronavirus vaccines. Npj Viruses 2, 39 (2024).","journal-title":"Npj Viruses"},{"key":"75678_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11684-024-1066-6","volume":"18","author":"B Hu","year":"2024","unstructured":"Hu, B., Guo, H., Si, H. & Shi, Z. Emergence of SARS and COVID-19 and preparedness for the next emerging disease X. Front. Med. 18, 1\u201318 (2024).","journal-title":"Front. Med."},{"key":"75678_CR64","doi-asserted-by":"publisher","first-page":"e0151121","DOI":"10.1128\/JVI.01511-21","volume":"96","author":"ES Winkler","year":"2021","unstructured":"Winkler, E. S. et al. SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice. J. Virol. 96, e0151121 (2021).","journal-title":"J. Virol."},{"key":"75678_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"75678_CR66","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.cell.2020.04.011","volume":"181","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. The architecture of SARS-CoV-2 transcriptome. Cell 181, 914\u2013921.e910 (2020).","journal-title":"Cell"},{"key":"75678_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43856-021-00034-y","volume":"1","author":"CH Wong","year":"2021","unstructured":"Wong, C. H. et al. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection. Commun. Med. 1, 33 (2021).","journal-title":"Commun. Med."},{"key":"75678_CR68","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450\u2013454 (2003).","journal-title":"Nature"},{"key":"75678_CR69","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41392-021-00704-2","volume":"6","author":"Z Niu","year":"2021","unstructured":"Niu, Z. et al. N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding. Signal Transduct. Target Ther. 6, 284 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"75678_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103643","volume":"73","author":"H Shuai","year":"2021","unstructured":"Shuai, H. et al. Emerging SARS-CoV-2 variants expand species tropism to murines. EBioMedicine 73, 103643 (2021).","journal-title":"EBioMedicine"},{"key":"75678_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9929","volume":"7","author":"V Fumagalli","year":"2022","unstructured":"Fumagalli, V. et al. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci. Immunol. 7, eabl9929 (2022).","journal-title":"Sci. Immunol."},{"key":"75678_CR72","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","volume":"589","author":"J Zheng","year":"2020","unstructured":"Zheng, J. et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603\u2013607 (2020).","journal-title":"Nature"},{"key":"75678_CR73","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1080\/22221751.2020.1838955","volume":"9","author":"R Rathnasinghe","year":"2020","unstructured":"Rathnasinghe, R. et al. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg. Microbes Infect. 9, 2433\u20132445 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"75678_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10970-y","volume":"10","author":"E Platanitis","year":"2019","unstructured":"Platanitis, E. et al. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription. Nat. Commun. 10, 2921 (2019).","journal-title":"Nat. Commun."},{"key":"75678_CR75","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1042\/BJ20140644","volume":"466","author":"K Blaszczyk","year":"2015","unstructured":"Blaszczyk, K. et al. STAT2\/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1. Biochem. J. 466, 511\u2013524 (2015).","journal-title":"Biochem. J."},{"key":"75678_CR76","doi-asserted-by":"publisher","first-page":"11515","DOI":"10.1128\/JVI.01703-09","volume":"84","author":"NA Jewell","year":"2010","unstructured":"Jewell, N. A. et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J. Virol. 84, 11515\u201311522 (2010).","journal-title":"J. Virol."},{"key":"75678_CR77","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","volume":"9","author":"JJ Feld","year":"2021","unstructured":"Feld, J. J. et al. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir. Med. 9, 498\u2013510 (2021).","journal-title":"Lancet Respir. Med."},{"key":"75678_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34709-4","volume":"13","author":"DM Santer","year":"2022","unstructured":"Santer, D. M. et al. Interferon-\u03bb treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity. Nat. Commun. 13, 6992 (2022).","journal-title":"Nat. Commun."},{"key":"75678_CR79","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706\u2013712 (2020).","journal-title":"Science"},{"key":"75678_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear, H. M., Schoggins, J. W. & Diamond, M. S. Shared and distinct functions of type I and type III interferons. Immunity 50, 907\u2013923 (2019).","journal-title":"Immunity"},{"key":"75678_CR81","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adf5494","volume":"16","author":"EV Mesev","year":"2023","unstructured":"Mesev, E. V. et al. Membrane-proximal motifs encode differences in signaling strength between type I and III interferon receptors. Sci. Signal. 16, eadf5494 (2023).","journal-title":"Sci. Signal."},{"key":"75678_CR82","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190295","volume":"217","author":"A Broggi","year":"2020","unstructured":"Broggi, A., Granucci, F. & Zanoni, I. Type III interferons: balancing tissue tolerance and resistance to pathogen invasion. J. Exp. Med. 217, e20190295 (2020).","journal-title":"J. Exp. Med."},{"key":"75678_CR83","doi-asserted-by":"publisher","first-page":"7944","DOI":"10.1073\/pnas.1100552108","volume":"108","author":"J Pott","year":"2011","unstructured":"Pott, J. et al. IFN-lambda determines the intestinal epithelial antiviral host defense. Proc. Natl. Acad. Sci. USA 108, 7944\u20137949 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"75678_CR84","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1126\/science.8009221","volume":"264","author":"U M\u00fcller","year":"1994","unstructured":"M\u00fcller, U. et al. Functional role of type I and type II interferons in antiviral defense. Science 264, 1918\u20131921 (1994).","journal-title":"Science"},{"key":"75678_CR85","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.1995.tb00090.x","volume":"148","author":"MF van den Broek","year":"1995","unstructured":"van den Broek, M. F., M\u00fcller, U., Huang, S., Zinkernagel, R. M. & Aguet, M. Immune defence in mice lacking type I and\/or type II interferon receptors. Immunol. Rev. 148, 5\u201318 (1995).","journal-title":"Immunol. Rev."},{"key":"75678_CR86","doi-asserted-by":"publisher","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","volume":"4","author":"M Mordstein","year":"2008","unstructured":"Mordstein, M. et al. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 4, e1000151 (2008).","journal-title":"PLoS Pathog."},{"key":"75678_CR87","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri, L. et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370, 856\u2013860 (2020).","journal-title":"Science"},{"key":"75678_CR88","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen, T. M. et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183, 1043\u20131057.e1015 (2020).","journal-title":"Cell"},{"key":"75678_CR89","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41422-020-00460-y","volume":"31","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res 31, 126\u2013140 (2021).","journal-title":"Cell Res"},{"key":"75678_CR90","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1016\/j.cell.2023.06.005","volume":"186","author":"J Baggen","year":"2023","unstructured":"Baggen, J. et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell 186, 3427\u20133442.e3422 (2023).","journal-title":"Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75678-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75678-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75678-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:04:42Z","timestamp":1787792682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75678-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75678"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75678-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9122"}}